Definition
R&D strategy governs idea sourcing, selection, development, and commercialization to convert science/insight into profitable offerings.

Introduction
Innovation is a pipeline, not serendipity: front-end exploration, gated development, and launch excellence.

Explanation

Portfolio: core (incremental), adjacent, transformational—balance risk/return.

Stage-gate: problem fit → solution fit → feasibility → field trials → scale; kill rules and evidence thresholds.

Open innovation: universities, startups, suppliers; IP strategy (patents, trade secrets, licenses).

Time-to-value: design for manufacturability, pilot cells, digital twins.

Metrics: R&D intensity, hit rate, time-to-market, % revenue from <3-year launches. Key Takeaways Kill quickly, scale decisively; celebrate smart stops. Protect and leverage IP; partner for speed. Tie R&D to market outcomes, not patents alone. Real-World Case Moderna operationalized mRNA R&D with platform reuse, digital labs, and rapid clinical staging—dramatically compressing development cycles. Reference: Moderna platform briefs.